A new paradigm in wound healing
Keratin is the key structural material making up the outermost layer of our skin. In addition to its vital role as a physical structure, research into keratin function at some of the world's leading medical universities has identified the crucial biological role that keratin proteins play in the wound healing process.
Keraplast's Replicine™ Functional Keratin® technology has captured, for the first time, the native form and function of keratin proteins. This unique technology has demonstrated the ability to activate keratinocytes, increase epithelization rates and enhance production of important basement membrane proteins to improve healed skin structure.
Based on an extensive international research program, and a strong evidence base of efficacy in wound healing, Keraplast has developed three advanced wound healing products to deliver Replicine™ Functional Keratin® technology to the wound bed and manage a broad range of wound types. Clinical efficacy has been demonstrated in:
- Improving skin condition and quality of life for those living with epidermolysis bullosa
- Venous leg ulcers
- Arterial ulcers
- Diabetic foot ulcers
- Pressure ulcers
- Skin graft donor sites
- First and second degree burns
- Skin tears
- Superficial injuries, cuts, abrasions and surgical wounds
See experts present information on keratin wound care at the SAWC convention.
- Dr Rob Kelly introduces Replicine™ Functional Keratin® wound care technology.
- Dr Marjana Tomic-Canic discusses keratin biology and the role of keratin in epithelization.
- Dr Robert Kirsner discusses clinical experience in chronic wounds and epidermolysis bullosa.
Keraplast Advanced Wound Healing Products
Keraplast advanced wound healing products are founded on extensive research and an ongoing clinical program across a range of wound types. Find out more.
- Formulated for convenient application to delicate skin, keragelT® is used in the management of the skin disorder epidermolysis bullosa (EB).
More information about keragelT® for EB families and clinicians.
keragel™ is a keratin-rich gel designed for chronic dry wounds, acute wounds and skin disorders. keragel® provides moisture to a dry wound as well as a keratin environment to encourage cell growth, leading to an excellent healing outcome.More information about keragel® for pateints and clinicians.
keramatrix® is an absorbable matrix rich in keratin protein that delivers Replicine™ Functional Keratin® as it dissolves into the wound. Due to the unique biological function of keratin protein, keramatrix® delivers a level performance typically associated with high cost biological dressings, in a much lower cost and much more convenient format.
More information about keramatrix for patients and clinicians.
kerasorb® is a multilayer dressing with a keratin wound contact surface backed by a highly absorbent polyurethane foam. Designed for highly exudating wounds, kerasorb® provides keratin to the wound surface while effectively managing wound exudate.
Keraplast advanced wound healing products are approved by regulatory agencies in several major regions of the world including:
- US FDA
- European Union through the CE mark system
- Australian TGA
- New Zealand Medsafe
Keraplast advanced wound healing products have the CE mark and are produced in dedicated manufacturing facilities certified by TUV SUD to the international medical device standard ISO 13485.